Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer
Where
Hangzhou
Age
18 years and over
People
104
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06523673
No phaseNot yet taking people in China
Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer
Where
Nanchang, Shanghai, Ürümqi, Wenzhou, Wuhan
Age
18 years and over
People
134
Run by
Shanghai Chest Hospital
See details and how to joinNCT06580665
Phase 2Taking people
Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis
Where
Shanghai
Age
18 years and over
People
54
Run by
Fudan University
See details and how to joinNCT06501391
Phase 4Taking people
Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients
Where
Shanghai
Age
18 years to 75 years
People
592
Run by
Fudan University
See details and how to joinNCT06561620
Phase 2Taking people
Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
Where
Guangzhou
Age
18 years to 99 years
People
100
Run by
Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT04770207
Phase 2Taking people
Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer
Where
Hangzhou
Age
18 years to 75 years
People
20
Run by
Zhejiang Cancer Hospital
See details and how to joinNCT06562920
No phaseTaking people
BAI-BACE for Advanced Lung Squamous Cell Carcinoma
Where
Beijing
Age
18 years to 80 years
People
85
Run by
Sun Yat-sen University
See details and how to joinNCT06377735
Phase 2Not yet taking people in China
A Multicenter Randomized Controlled Study of Interventional Treatment for Operable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer With Potential Recurrence as Minimal Residual Disease(MRD) Positive
Where
Beijing
Age
18 years to 80 years
People
213
Run by
Xuanwu Hospital, Beijing
See details and how to joinNCT06524518
Phase 3Taking people
Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors
Where
Changsha
Age
18 years and over
People
12,000
Run by
Hunan Province Tumor Hospital
See details and how to joinNCT05055908
No phaseTaking people
Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
Where
Shanghai
Age
18 years to 75 years
People
50
Run by
Ruijin Hospital
See details and how to joinNCT06534489
Phase 2Taking people
Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
Where
Hangzhou
Age
18 years to 65 years
People
260
Run by
Zhejiang Provincial People's Hospital
See details and how to joinNCT06534762
Phase 2Taking people
Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma
Where
Shanghai
Age
18 years to 74 years
People
62
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT06528847
Phase 2Taking people
Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
Where
Guangzhou
Age
18 years and over
People
23
Run by
Sun Yat-sen University
See details and how to joinNCT06517953
No phaseTaking people
Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer
Where
Qingdao
Age
18 years to 80 years
People
70
Run by
Qingdao Central Hospital
See details and how to joinNCT06514118
Phase 2Taking people
Serplulimab Combined With CCRT for LS-SCLC.
Where
Beijing
Age
18 years and over
People
96
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06295926
No phaseTaking people
The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis
Where
Guangzhou
Age
18 years to 75 years
People
118
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT06244264
Phase 2Taking people
Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.
Where
Guanzhou
Age
18 years to 75 years
People
90
Run by
Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06492421
Phase 1/2Taking people
A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC
Where
Changsha, Hefei, Linhai, Nanjing, Shanghai, Zhengzhou
Age
18 years and over
People
94
Run by
Suzhou Genhouse Bio Co., Ltd.
See details and how to joinNCT06306456
Phase 2Taking people
Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT
Where
Guangzhou
Age
18 years to 75 years
People
90
Run by
Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06483347
Phase 2Taking people
Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial
Where
Xi'an
Age
18 years to 75 years
People
104
Run by
Tang-Du Hospital
See details and how to joinNCT06485544
No phaseTaking people
Risk Factors for Postoperative Cough in Patients Undergoing Thoracoscopic Lung Resection
Where
Kunming
Age
18 years to 70 years
People
1,000
Run by
Hematology department of the 920th hospital
See details and how to joinNCT06476249
Phase 2/3Taking people
Interventional Software for Multi-immunotherapy of Solid Tumors
Where
Guangzhou
Age
18 years to 75 years
People
60
Run by
Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06478108
Phase 1Taking people
Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors
Where
Guangzhou
Age
18 years to 80 years
People
50
Run by
Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT04952272
Phase 1Taking people
GPC3/Mesothelin-CAR-γδT Cells Against Cancers
Where
Guangzhou
Age
18 years to 75 years
People
30
Run by
Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06196294
Phase 2Taking people
Adebrelimab + Apatinib in SCLC Maintenance Therapy
Where
Xi'an
Age
18 years to 75 years
People
60
Run by
Tang-Du Hospital
See details and how to joinNCT06475209